Patents by Inventor Amos Douvdevani

Amos Douvdevani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PERITONEAL SODIUM-GLUCOSE TRANSPORTER (SGLT) INHIBITORS FOR IMPROVEMENT OF PERITONEAL DIALYSIS
    Publication number: 20210220379
    Abstract: Peritoneal dialysis fluid (PDF) comprising at least one inhibitor of glucose transport and compositions comprising same are provided. Use of a PDF and a glucose transport inhibitor such as a sodium-glucose co-transporter (SGLT) inhibitor decreases glucose absorption into the circulation of patients treated with peritoneal dialysis and, therefore, provides improved means for treating renal failure diseases.
    Type: Application
    Filed: August 30, 2018
    Publication date: July 22, 2021
    Inventors: Marina VOROBIOV, Amos DOUVDEVANI, Yosef HAVIV, Boris ROGCHEV
  • NUCLEIC ACID DETECTION ASSAY
    Publication number: 20150299805
    Abstract: This invention is directed, inter alia, to methods and kits for rapid, easy and cost-effective methods of breast cancer prediction and diagnosis in inter alia, blood samples.
    Type: Application
    Filed: January 9, 2015
    Publication date: October 22, 2015
    Applicants: BEN GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY, MOR RESEARCH APPLICATIONS LTD.
    Inventor: Amos Douvdevani
  • Antisense oligomer
    Publication number: 20020082230
    Abstract: An antisense oligomer capable of inhibiting production of interleukin-15 (IL-15) by hybridizing to the mRNA of IL-15. Also disclosed is a pharmaceutical composition for treating diseases associated with the production of IL-15 comprising said antisense oligomer and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: May 4, 2001
    Publication date: June 27, 2002
    Inventors: Amos Douvdevani, Cidio Chaimovitz